Conference Highlights: IAS 2021
New research was presented at IAS 2021, the virtual 11th International AIDS Society Conference on...
Read MoreJul 27, 2021
New research was presented at IAS 2021, the virtual 11th International AIDS Society Conference on...
Read MoreJul 20, 2021
A study has found that opioid prescriptions, including receipt of prescriptions for long...
Read MoreJun 9, 2021
Hepatocellular carcinoma (HCC) is the fourth most prevalent cause of cancer-related death...
Read MoreJan 21, 2020
Despite treatment, elderly patients with cancer who are HIV-positive had worse outcomes than those...
Read MoreJan 3, 2020
For HIV-positive individuals who begin antiretroviral therapy (ART) at CD4 counts below 500...
Read MoreDec 17, 2019
New research was presented at IDWeek 2019, the joint annual meeting of the Infectious Diseases...
Read MoreNov 7, 2019
Despite overall progress in HIV prevention and treatment, the condition continues to...
Read MoreAug 11, 2019
Screening patients with newly diagnosed cancer to identify hepatitis B and C infections before...
Read MoreJul 26, 2019
New research was presented at IAS 2019, the 10th International AIDS Society Conference on HIV...
Read MoreJul 1, 2019
New research was presented at ASM Microbe 2019, the joint annual meeting of the American Society...
Read MoreMay 13, 2019
IM residents with training report more frequent prescribing, higher comfort level in educating patients
Read MoreMay 3, 2019
By Kate Kelland LONDON (Reuters) – A European study of nearly 1,000 gay male couples who had...
Read MoreMay 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gender Differences Seen in Adverse Drug […]
Read MoreMay 1, 2019
Facial involves injecting nutrient-rich plasma into the face using a microneedling pen
Read MoreApr 8, 2019
By Ludwig Burger (Reuters) – GlaxoSmithKline Plc’s two-drug treatment for HIV...
Read MoreApr 8, 2019
Dovato indicated for use in patients with no history of antiretroviral treatment
Read MoreMar 8, 2019
New research was presented at CROI 2019, the annual Conference on Retroviruses and Opportunistic...
Read MoreJan 14, 2019
As of 2010, Kaposi sarcoma (KS) accounted for 12% of cancer diagnoses in people living with HIV or...
Read MoreDec 26, 2018
By Andy Skean Senior Editor Numerous studies have illustrated the ability of antiretroviral...
Read MoreDec 23, 2018
By Andy Skean Senior Editor In 2014, the CDC published comprehensive clinical practice...
Read More